This compound is an Fmoc-protected, alpha-methylated derivative of 2,6-difluorophenylalanine, commonly used as a building block in solid-phase peptide synthesis. Its structure incorporates a fluorenylmethoxycarbonyl (Fmoc) group for temporary amine protection, enabling the stepwise assembly of peptides containing a sterically hindered, fluorinated amino acid residue.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1223105-51-8
FMoc-alpha-Me-D-Phe(2-F)-OH
pharmaceutical intermediate
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-fluorophenyl)-2-methylpropanoic acid
research compound
Fmoc-L-tert-leucine
research compound
N-Fmoc-L-Glutamine
research compound
N-fmoc-L-norleucine
research compound
Fmoc-D-proline
research compound
Reactive Red 31
research compound
(4-(benzyloxy)-3,5-difluorophenyl)methanol
research compound
(2S)-3-(2,6-difluorophenyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methylpropanoic acid
MRIVYBRWULFPFJ-VWLOTQADSA-N
C[C@](CC1=C(C=CC=C1F)F)(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24